- Home
- ORKA vs WERN Comparison
ORKA vs WERN Comparison
Compare ORKA & WERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORKA | WERN |
|---|---|---|
| Founded | 2004 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ORKA | WERN |
|---|---|---|
| Price | $34.39 | $33.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 13 |
| Target Price | ★ $49.73 | $30.38 |
| AVG Volume (30 Days) | 533.1K | ★ 940.0K |
| Earning Date | 03-05-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 1.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.41 |
| Revenue | N/A | ★ $2,991,440,000.00 |
| Revenue This Year | N/A | $1.01 |
| Revenue Next Year | N/A | $3.79 |
| P/E Ratio | ★ N/A | $84.07 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.49 | $23.02 |
| 52 Week High | $36.51 | $38.60 |
Technical Indicators
Market Signals| Indicator | ORKA | WERN |
|---|---|---|
| Relative Strength Index (RSI) | 62.49 | 63.78 |
| Support Level | $25.79 | $31.98 |
| Resistance Level | $36.51 | $33.70 |
| Average True Range (ATR) | 2.07 | 1.03 |
| MACD | 0.59 | 0.01 |
| Stochastic Oscillator | 80.05 | 80.07 |
Price Performance
Historical ComparisonAbout ORKA Oruka Therapeutics Inc.
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.